John MacMahon, CytoKind - UVB Light to Treat Immune Disorders | LSI USA '24

CytoKind is a leader in using ultraviolet (UVB) light to treat immune disorders and improve outcomes for patients.

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow